Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

被引：1
|
作者：
Kikuchi, Taku [1 ,2 ]
Tsukada, Nobuhiro [1 ]
Kunisada, Kodai [1 ]
Yogo, Moe [1 ]
Oda, Yuki [1 ]
Sato, Kota [1 ]
Takei, Tomomi [1 ]
Ogura, Mizuki [1 ]
Abe, Yu [1 ]
Suzuki, Kenshi [1 ]
Ishida, Tadao [1 ]
机构：
[1] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
[2] Japanese Red Cross Med Ctr, Dept Hematol, 4 Chome-1-22 Hiroo, Tokyo 1508935, Japan
来源：
HEMATOLOGICAL ONCOLOGY | 2024年 / 42卷 / 01期
关键词：
MINIMAL RESIDUAL DISEASE; LENALIDOMIDE MAINTENANCE;
D O I：
10.1002/hon.3248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation
    Williams, Alexis
    Baruah, Dhiraj
    Patel, Jayshil
    Szabo, Aniko
    Chhabra, Saurabh
    Dhakal, Binod
    Hari, Parameswaran
    Janz, Siegfried
    Stolley, Melinda
    D'Souza, Anita
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 225 - 231
  • [42] Cost Analysis for Adult Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplantation
    Lopes, Danielle Ovigli
    Silva, Cinthya
    Teich, Vanessa
    Malheiro, Daniel
    Arcuri, Leonardo
    Ribeiro, Andreza
    Kerbauy, Mariana
    Helman, Ricardo
    Pagliuso, Joao
    Marques, Carolina
    Moura, Fernando
    Pina, Bruno
    Rocha, Juliana
    Kerbauy, Lucila
    Hamerschlak, Nelson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S245 - S246
  • [43] Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
    Ciftciler, Rafiye
    Goker, Hakan
    Demiroglu, Haluk
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Aksu, Salih
    Ozcebe, Osman
    Buyukasik, Yahya
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (01) : 33 - 40
  • [44] Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma
    Al Hadidi, Samer
    Ababneh, Obada
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Bailey, Clyde
    Tricot, Guido
    Shaughnessy Jr, John
    Zhan, Fenghuang
    Sawyer, Jeffrey
    Siegel, Eric R.
    Zangari, Maurizio
    Barlogie, Bart
    van Rhee, Frits
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (11) : 2222 - 2224
  • [45] Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    Uy, GL
    Fisher, NM
    Devine, SM
    Adkins, DR
    Tomasson, MH
    Graubert, TA
    DiPersio, JF
    Vij, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 77 - 77
  • [46] PROGNOSTIC SIGNIFICANCE OF BEHAVIORAL SYMPTOMS FOR MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
    Costanzo, Erin S.
    Rumble, Meredith E.
    Juckett, Mark B.
    Coe, Christopher L.
    Hematti, Peiman
    Callander, Natalie S.
    PSYCHOSOMATIC MEDICINE, 2018, 80 (03): : A83 - A83
  • [47] Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation
    Landau, Heather
    Wood, Kevin
    Chung, David J.
    Koehne, Guenther
    Lendvai, Nikoletta
    Hassoun, Hani
    Lesokhin, Alexander
    Hoover, Elizabeth
    Zheng, Junting
    Devlin, Sean M.
    Giralt, Sergio
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1781 - 1785
  • [48] Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM
    Kumar, Sathish
    D'Souza, Anita
    Scott, Emma C.
    Fraser, Raphael
    Davila, Omar
    Gasparetto, Cristina J.
    Kumar, Shaji K.
    Mark, Tomer M.
    Nieto, Yago
    Hari, Parameswaran
    BLOOD, 2017, 130
  • [49] Adverse prognostic factors for survival in patients with Multiple Myeloma undergoing Allogenic Hematopoietic Stem-Cell Transplantation
    Garcia Torres, E.
    Martin Calvo, C.
    Rojas Contreras, R.
    Casano, J.
    Serrano Lopez, J.
    Tavares Carrasco, S.
    Alvarez Rivas, M. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S221 - S221
  • [50] REVISED-INTERNATIONAL STAGING SYSTEM (R-ISS): A NEW AND SIMPLE PROGNOSTIC ASSESSMENT FOR MULTIPLE MYELOMA
    Oliva, S.
    Caltagirone, S.
    Passera, R.
    Van der Holt, B.
    Hardan, I.
    Nozza, A.
    Zamagni, E.
    Musto, P.
    Omede, P.
    Zweegman, S.
    Baldini, L.
    Bringhen, S.
    Lokhorst, H.
    Ria, R.
    Zambello, R.
    Ruggeri, M.
    Broijl, A.
    Pezzatti, S.
    Hajek, R.
    Tacchetti, P.
    Pozzi, S.
    Cornelissen, P.
    Spencer, A.
    Boccadoro, M.
    Cavo, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 496 - 496
12345